Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Soloway Thomas P Create: Alert

All | News | Filings
Date FiledTypeDescription
06/08/2023 4 Soloway Thomas P (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.
Txns: Disposed/sold 20,000 options to buy @ $27.25, valued at $545k
Disposed/sold 20,000 options to buy @ $4.6, valued at $92k
Disposed/sold 30,000 options to buy @ $3.46, valued at $103.8k
06/08/2023 4 Soloway Thomas P (Director) has filed a Form 4 on Third Harmonic Bio, Inc.
Txns: Granted 16,250 options to buy @ $5.03, valued at $81.7k
03/08/2023 4 Soloway Thomas P (Director) has filed a Form 4 on Third Harmonic Bio, Inc.
Txns: Disposed/sold 76,582 options to buy @ $8.61, valued at $659.4k
Granted 76,582 options to buy @ $4.2, valued at $321.6k
Disposed/sold 13,667 options to buy @ $17.83, valued at $243.7k
Granted 13,667 options to buy @ $4.2, valued at $57.4k
10/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/14/2022 3 Soloway Thomas P (Director) has filed a Form 3 on Third Harmonic Bio, Inc.
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/07/2020 4 Soloway Thomas P (Director) has filed a Form 4 on Satsuma Pharmaceuticals, Inc.
Txns: Granted 20,000 options to buy @ $4.6, valued at $92k
07/07/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/07/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
01/15/2020 4 Soloway Thomas P (Executive Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Unknown transaction of 183,384 shares @ $60, valued at $11M
Disposed/sold 3,829 options to buy @ $2.7649, valued at $10.6k
Disposed/sold 6,263 options to buy @ $9.4988, valued at $59.5k
Disposed/sold 73,781 options to buy @ $15.26, valued at $1.1M
Disposed/sold 75,000 options to buy @ $27.39, valued at $2.1M
Disposed/sold 65,000 options to buy @ $24.74, valued at $1.6M
01/10/2020 4 Soloway Thomas P (Executive Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Exercised 144,669 options to buy @ $2.7649, valued at $400k
Exercised 6,219 options to buy @ $15.26, valued at $94.9k
12/16/2019 4 Soloway Thomas P (Executive Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Paid exercise price by delivering 8,681 shares @ $59.37, valued at $515.4k
Paid exercise price by delivering 21,458 shares @ $59.37, valued at $1.3M
Exercised 41,321 options to buy @ $2.7649, valued at $114.2k
12/09/2019 4 Soloway Thomas P (Executive Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Paid exercise price by delivering 505 shares @ $59.21, valued at $29.9k
09/09/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2019 4 Soloway Thomas P (Executive Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,009 shares @ $37.31, valued at $37.6k
02/08/2019 4 Soloway Thomas P (Executive Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Granted 23,333 shares @ $0
Granted 65,000 options to buy @ $24.74, valued at $1.6M
11/17/2017 4 Soloway Thomas P (Senior Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Granted 75,000 options to buy @ $27.39, valued at $2.1M
01/27/2017 4 Soloway Thomas P (Senior Vice President, CFO) has filed a Form 4 on Audentes Therapeutics, Inc.
07/19/2016 3 Soloway Thomas P (Senior Vice President, CFO) has filed a Form 3 on Audentes Therapeutics, Inc.
07/18/2013 4 Form 4 - Statement of changes in beneficial ownership of securities
01/08/2013 4 Soloway Thomas P (EVP, COO) has filed a Form 4 on Transcept Pharmaceuticals Inc
Txns: Granted 140,000 options to buy @ $5.4, valued at $756k
02/02/2012 4 Soloway Thomas P (SVP, Operations and CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc
Txns: Granted 60,000 options to buy @ $8.09, valued at $485.4k
12/05/2011 4 Soloway Thomas P (SVP, Operations and CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc
Txns: Sold 25,150 shares @ $8.2325, valued at $207k
Sold 37,520 shares @ $8.5671, valued at $321.4k
Exercised 25,150 options to buy @ $2.68, valued at $67.4k
Exercised 37,520 options to buy @ $0.8844, valued at $33.2k
11/28/2011 4 Soloway Thomas P (SVP, Operations and CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc
Txns: Sold 13,600 shares @ $7.865, valued at $107k
Exercised 13,600 options to buy @ $2.68, valued at $36.4k
08/25/2011 4 Soloway Thomas P (SVP, Operations and CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc
Txns: Granted 77,500 options to buy @ $2.68, valued at $207.7k
02/03/2011 4 Soloway Thomas P (SVP, Operations and CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc
Txns: Granted 58,000 options to buy @ $8.2, valued at $475.6k
01/19/2010 4 Form 4 - Statement of changes in beneficial ownership of securities
02/17/2009 4 Soloway Thomas P (SVP, Operations and CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc
02/03/2009 4 Soloway Thomas P (SVP, Operations and CFO) has filed a Form 4 on Transcept Pharmaceuticals Inc
02/03/2009 3 Soloway Thomas P (SVP, Operations and CFO) has filed a Form 3 on Transcept Pharmaceuticals Inc

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy